ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,187.42
0.00%
S&P 500
5,187.67
0.00%
Dow Jones
39,056.39
0.44%
US Dollar vs Yen
155.5545
0.52%
Brent Oil
83.64
0.10%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. CytoSorbents Corporation (CTSO)

  7. CytoSorbents Corporation (CTSO) ニュース

CTSO CytoSorbents Corporation

0.87
-0.0622 (-6.67%)
取引時間後
最終更新日： 08:44:51
15分遅延
名称 銘柄コード 市場 種別
CytoSorbents Corporation CTSO NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
-0.0622 -6.67% 0.87 08:44:51
始値 安値 高値 終値 前日終値
0.9681 0.844801 0.9681 0.8719 0.9322
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0706:00EDGAR2Form 8-K - Current report
2024/5/0220:00GLOBECytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor..
2024/4/2620:00GLOBECytoSorbents to Report First Quarter 2024 Operating and..
2024/4/1720:00GLOBESTAR-T Pivotal Trial Results to Be Featured as a..
2024/3/0621:00GLOBECytoSorbents to Report Fiscal 2023 Operating and Financial..
2024/2/0821:00GLOBECytoSorbents to Present at the TD Cowen 44th Annual Health..
2024/1/1807:20EDGAR2Form 8-K - Current report
2024/1/1721:15GLOBEGroundbreaking Randomized Controlled Trial Reports Excellent..
2024/1/0905:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/12/2906:49EDGAR2Form 8-K - Current report
2023/12/2821:00GLOBECytoSorbents Provides Update on the STAR-T Trial and Reports..
2023/12/1606:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1606:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1606:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1606:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1606:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1606:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1606:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1606:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1323:15EDGAR2Form 8-K - Current report
2023/12/1323:15GLOBECytoSorbents Announces Closing of $10.3 Million Registered..
2023/12/1206:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/1206:10EDGAR2Form 8-K - Current report
2023/11/1006:20EDGAR2Form 8-K - Current report
2023/11/1006:15GLOBECytoSorbents Reports Third Quarter 2023 Financial and..
2023/11/1006:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/2720:00GLOBECytoSorbents to Report Third Quarter 2023 Operating and..
2023/10/0520:00GLOBECytoSorbents to Present at the 8th Annual Dawson James..
2023/9/2721:15EDGAR2Form 8-K - Current report
2023/9/2720:00GLOBECytoSorbents Highlights Upcoming Presentations at EACTS..
2023/9/2122:35GLOBEDawson James Securities Announces October Date for 8th..
2023/9/2105:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2005:30EDGAR2Form 8-K - Current report
2023/9/1920:00GLOBECytoSorbents Announces Kathleen P. Bloch To Resume as..
2023/9/1305:31EDGAR2Form 8-K - Current report
2023/9/1200:32GLOBECytoSorb with Ex Vivo Organ Perfusion: Transforming the..
2023/9/0205:43GLOBECytoSorbents Announces Resignation of Chief Financial..
2023/9/0205:30EDGAR2Form 8-K - Current report
2023/8/3120:00GLOBECytoSorbents Granted Expanded ANVISA Registration to Treat..
2023/8/1606:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/8/1420:00PRNUSCytoSorbents Completes U.S. and Canadian STAR-T Pivotal..
2023/8/1206:30EDGAR2Form 8-K - Current report
2023/8/0909:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0205:15GLOBECytoSorbents Reports Second Quarter 2023 Financial and..
2023/8/0205:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/7/2620:00GLOBECytoSorbents to Report Second Quarter 2023 Operating and..
2023/7/2006:19EDGAR2Form 8-K - Current report
2023/7/1209:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1209:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1209:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

NASDAQ
CTSO
CytoSorbents
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有